The call ran from 5:31 PM to 6:30 PM IST (59 min).
Key takeaways
Q2 consolidated revenue ₹511 Cr (+23%), operating EBITDA ₹120 Cr (+47%), PAT ₹40.3 Cr. Strong operating leverage, but receivables rose to ₹518 Cr, weakening cash conversion (H1 OCF ₹68 Cr). No numeric guidance given.
| Revenue growth | Q2 revenue ₹511 Cr, up 23% YoY; H1 ₹981 Cr, up 25%. |
|---|---|
| Margins | Q2 operating EBITDA margin 23.5%, up 390bps YoY; mature cohort 29.6%. |
| Demand visibility | Occupancy up to 73% H1 from 59%; Rajasthan state scheme suspended. |
| Management confidence | Confident; declined numeric guidance, flagged Udaipur softness. |
Growth
Operating EBITDA margin up 390bps to 23.5%; growth led by new hospitals (+139%) and volume (inpatient +27.3%). Price split undisclosed.
Outlook
No numeric guidance; beds rise to ~1,800 by H2 FY27, with Gurugram (300) and Ludhiana (500) to follow.
Risks
Receivables ₹350 Cr to ₹518 Cr (Mar–Sep), H1 operating cash flow only ₹68 Cr; Rajasthan government scheme suspension hits Udaipur.
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Paras Healthcare Q2 FY27 Results: Net Profit ₹40.4 Cr, Up 225.8% YoY
Paras Healthcare Ltd reported revenue from operations of ₹510.9 Cr (+22.8% YoY) and net profit of ₹40.4 Cr (+225.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹40.4 Cr · +225.8% YoY
Call details
| Company | Paras Healthcare Limited |
|---|---|
| NSE symbol | PARASHLTH |
| ISIN | INE661T01029 |
| Call | Q2 FY27 earnings call |
| Date | Friday, 6 November 2026 |
| Time | 5:30 PM IST |
| Length | 59 min |
| Audio | Our stream on YouTube ↗ |
Paras Healthcare Limited: key numbers
- Share price
- ₹843.00
- Market cap
- ₹9,121 Cr
- Revenue (annual)
- ₹1,606 Cr
- Net profit (annual)
- ₹43.83 Cr
- Promoter holding
- 63.95%
- FII holding
- 11.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.